Connect your AI

Agilon Health AGL Investment Proceeds

Investment Proceeds at other companies

InnovAge Holdings, Inc.INNV

$0-100%

CenteneCNC

$1.28B+3.2%

Other financials

Income statement

Revenue$1.4B-7.3%

Operating income$4.0M+118%

Net income$48.9M+304%

EPS (diluted)$2.94+303%

Balance sheet

Cash & equivalents$211.6M+52.6%

Total debt$33.4M-20.5%

Total equity$181.4M-63.7%

Total assets$1.5B-22.1%

Cash flow

Operating cash flow$23.7M+174%

CapEx$3.1M-19.4%

Free cash flow$20.6M+158%

Valuation

Market cap$1.78B-92.6%

Enterprise value$1.61B-103%

P/S0.3×-3.8×

Profitability

Operating margin-7.5%+6.5pp

Net margin-6.1%+6.3pp

FCF margin-1.1%—

Returns & leverage

Return on equity-104%-291pp

Debt / equity0.2×+0.1×

Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Agilon Health's investment proceeds?: Agilon Health (AGL) reported investment proceeds of $22.4M in Q1 2026.
How has Agilon Health's investment proceeds changed year-over-year?: Agilon Health's investment proceeds decreased by 36.6% year-over-year, from $35.31M to $22.4M.
What is the long-term trend for Agilon Health's investment proceeds?: Over 3 years (2021 to 2025), Agilon Health's investment proceeds has grown at a 201.2% compound annual growth rate (CAGR), from $7.1M to $193.87M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.